SHS Gesellschaft für Beteiligungsmanagement mbH

News

Current news of SHS and our portfolio companies

26. January 2024 - SHS News

Moderate growth in medical technology in Germany: Regulatory hurdles slow down innovation

Tübingen, 27.11.2023 Die Auswertung des SHS-Medizintechnik-Index 2022 zeigt eine stagnierende Entwicklung in der deutschen Medizintechnikbranche. Der Index, seit 2019 jährlich in Zusammenarbeit zwischen SHS Capital und Prof. Dr. Koziol, Lehrstuhlinhaber Finance an der Universität Tübingen, erstellt, zeigt nur eine moderate Zunahme von einem Prozentpunkt gegenüber dem Vorjahr. Der Medizintechnik-Index bildet die Wachstumsfähigkeit, die Innovationskraft und […]

Read more
26. January 2024 - SHS News

SHS Capital sells shares in joint protection expert Betterguards Technology GmbH

Tübingen / 14.12.2023 SHS Capital verkauft ihre Anteile am Berlin-Brandenburger Unternehmen an die Hochpfiffig GmbH, die das Unternehmen bei seiner weiteren Internationalisierung unterstützen wird. Die 2014 gegründete Betterguards Technology GmbH entwickelt und produziert intelligente Gelenkschutz-Bauteile, die in Sportschuhe, Bandagen und Arbeitsschuhe integriert werden können. Die den Bauteilen zugrunde liegende Technologie vereint Bewegungsfreiheit und Schutz. Der […]

Read more
13. September 2023 - SHS News

Healthcare Specialist SHS Capital announces Final Closing of its oversubscribed Sixth Fund Generation totaling EUR 270 million

The German Private Equity Investor SHS Capital has completed the Final Closing of its sixth fund generation The targeted fund volume of EUR 200 million could significantly be overachieved with ca. EUR 270 million and is more than doubling the predecessor fund’s size The new fund will invest in European growing healthcare companies and allocates […]

Read more
10. August 2023 - SHS News

Healthcare specialist SHS Capital acquires Majority Stake in Life Science Robotics Company ESSERT

SHS Capital has acquired a majority stake in the Baden-Württemberg-based robotics company ESSERT GmbH ESSERT develops intelligent automation solutions for a wide range of applications with a focus on the pharmaceutical, life science and general industrial sectors The company’s core product is the ESSERT MicroFactory, a modular production platform for the automation of low-volume, high-mix […]

Read more
1. August 2023 - Newsletter

This year the annual SHS Investors Day and the shareholders’ meetings of the SHS funds were held again in Tübingen

Our investors, portfolio representatives, SHS senior advisors and healthcare experts were invited to the Hotel Krone in the centre of Tübingen. The day offered exciting presentations on healthcare investments and outlooks on economic developments and medical innovations in the coming years. Furthermore, four of the SHS portfolio companies gave exciting presentations about their companies and […]

Read more
1. August 2023 - Newsletter, Portfolio News

SHS offers its portfolio companies a regular workshop for mutual exchange and training purposes

Another format that SHS has specifically created for its portfolio companies is the SHS portfolio workshops. These take place quarterly, covering various topics. The aim is to discuss topics that concern a large proportion of the portfolio companies and to provide the companies the opportunity to exchange ideas and knowledge, to discuss approaches to solving […]

Read more
1. August 2023 - Newsletter

SHS Capital has launched a new training format – the SHS Academy – for its newer employees as well as current and former interns

The new training and networking format is created for newer employees as well as current and former interns and is intended to provide practical insights into selected topics from the private equity industry. Speakers are both external and experienced SHS colleagues. For the first session, SHS managed to secure Sebastian Schreiber from SySS as external […]

Read more
1. August 2023 - Newsletter, Portfolio News

Salvia reports successful first application for the treatment of severe migraines in humans

Salvia BioElectronics, a pioneering Dutch company specialising in the treatment and cure of severe migraines, announced the successful first implantation of its paper-thin neuromodulation solution. Migraine is the most common cause of disability in people under 50 and affects one in seven people, mainly women. More than five percent of migraine patients suffer from chronic […]

Read more
1. August 2023 - Newsletter, Portfolio News

PathoQuest announces strategic partnership with Oxford Nanopore Technologies

French company PathoQuest has entered into a strategic partnership with Oxford Nanopore Technologies to bring to market the first sequencing-based quality control test for the genetic characterisation of biopharmaceuticals. Most biologics are produced using genetically modified cell lines. For many cell therapies, the product itself is a genetically modified cell line. Throughout the development of […]

Read more
7. July 2023 - SHS News

Healthcare Specialist SHS Capital acquires majority stake in CAM Bioceramics to support and accelerate its future growth

CAM Bioceramics B.V., based in Leiden, the Netherlands, is a leading global manufacturer of innovative calcium phosphate solutions for Medtech and LifeScience applications Together with ING Corporate Investments and several Co-Investors, the German specialist healthcare investor acquires a majority stake in the company, while current owners remain significant shareholders This investment is the third transaction […]

Read more
1
23
...
Next Last